-
Je něco špatně v tomto záznamu ?
Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study
R. Cardoso, F. Guo, T. Heisser, M. Hackl, P. Ihle, H. De Schutter, N. Van Damme, Z. Valerianova, T. Atanasov, O. Májek, J. Mužík, MC. Nilbert, AJ. Tybjerg, K. Innos, M. Mägi, N. Malila, AM. Bouvier, V. Bouvier, G. Launoy, AS. Woronoff, M. Cariou,...
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem
NLK
ProQuest Central
od 2002-05-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2002-05-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2002-05-01 do Před 2 měsíci
Psychology Database (ProQuest)
od 2002-05-01 do Před 2 měsíci
- MeSH
- časná detekce nádoru * MeSH
- časové faktory MeSH
- dospělí MeSH
- incidence MeSH
- kolorektální nádory epidemiologie mortalita patologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- prediktivní hodnota testů MeSH
- registrace MeSH
- rozložení podle pohlaví MeSH
- senioři MeSH
- staging nádorů MeSH
- věkové rozložení MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Evropa MeSH
BACKGROUND: Colorectal cancer screening programmes and uptake vary substantially across Europe. We aimed to compare changes over time in colorectal cancer incidence, mortality, and stage distribution in relation to colorectal cancer screening implementation in European countries. METHODS: Data from nearly 3·1 million patients with colorectal cancer diagnosed from 2000 onwards (up to 2016 for most countries) were obtained from 21 European countries, and were used to analyse changes over time in age-standardised colorectal cancer incidence and stage distribution. The WHO mortality database was used to analyse changes over time in age-standardised colorectal cancer mortality over the same period for the 16 countries with nationwide data. Incidence rates were calculated for all sites of the colon and rectum combined, as well as the subsites proximal colon, distal colon, and rectum. Average annual percentage changes (AAPCs) in incidence and mortality were estimated and relevant patterns were descriptively analysed. FINDINGS: In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2·5% (95% CI -2·8 to -2·2) to -1·6% (-2·0 to -1·2) in men and from -2·4% (-2·7 to -2·1) to -1·3% (-1·7 to -0·9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0·2% (95% CI -1·4 to 1·0) to 1·5% (1·1 to 1·8) in men and from -0·5% (-1·7 to 0·6) to 1·2% (0·8 to 1·5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0·3% (95% CI 0·1 to 0·5) to 1·9% (1·2 to 2·6) in men and from 0·6% (0·4 to 0·8) to 1·1% (0·8 to 1·4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes. INTERPRETATION: We observed divergent trends in colorectal cancer incidence, mortality, and stage distribution across European countries, which appear to be largely explained by different levels of colorectal cancer screening implementation. FUNDING: German Cancer Aid (Deutsche Krebshilfe) and the German Federal Ministry of Education and Research.
Austrian National Cancer Registry Statistics Austria Vienna Austria
Basque Country Cancer Registry Vitoria Gasteiz Spain
Belgian Cancer Registry Brussels Belgium
Bulgarian National Cancer Registry University Hospital of Oncology Sofia Bulgaria
Cancer Registry Bern Solothurn Bern Switzerland
Cancer Registry of Doubs Centre Hospitalier Régional Universitaire Besançon Besançon France
Cancer Registry of Eastern Switzerland and Liechtenstein St Gallen Switzerland
Cancer Registry of Isère French Network of Cancer Registries Grenoble France
Cancer Registry of Norway Oslo Norway
Cancer Registry of Schleswig Holstein Lübeck Germany
Consortium for Biomedical Research in Epidemiology and Public Health Madrid Spain
Danish Cancer Society Research Center Copenhagen Denmark
Department of Clinical Medicine University of Bergen Bergen Norway
Department of Clinical Sciences Center for Primary Health Care Research Lund University Malmö Sweden
Department of Epidemiology Regional Health Council IMIB Arrixaca Murcia University Murcia Spain
Department of Gastrointestinal Surgery Stavanger University Hospital Stavanger Norway
Department of Public Health Erasmus MC University Medical Center Rotterdam Rotterdam Netherlands
Department of Research University Hospital of Caen Caen France
Department of Surgery Haukeland University Hospital Bergen Norway
Estonian Cancer Registry National Institute for Health Development Tallinn Estonia
German Cancer Consortium German Cancer Research Center Heidelberg Germany
Graubünden and Glarus Cancer Registry Chur Switzerland
Institute of Biostatistics and Analyses Faculty of Medicine Masaryk University Brno Czech Republic
Institute of Health Information and Statistics of the Czech Republic Prague Czech Republic
IPO Porto Research Center Portuguese Oncology Institute of Porto Porto Portugal
Lithuanian Cancer Registry National Cancer Institute Vilnius Lithuania
Medical Faculty Heidelberg University of Heidelberg Heidelberg Germany
National Cancer Registry Ireland Cork Ireland
National Cancer Registry of Ukraine National Institute of Cancer Kyiv Ukraine
Piedmont Cancer Registry Turin Italy
Portuguese National Cancer Registry Portuguese Oncology Institute of Lisbon Lisbon Portugal
Slovenian Cancer Registry Institute of Oncology Ljubljana Slovenia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21025479
- 003
- CZ-PrNML
- 005
- 20211026133752.0
- 007
- ta
- 008
- 211013s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/S1470-2045(21)00199-6 $2 doi
- 035 __
- $a (PubMed)34048685
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Cardoso, Rafael $u Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany
- 245 10
- $a Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study / $c R. Cardoso, F. Guo, T. Heisser, M. Hackl, P. Ihle, H. De Schutter, N. Van Damme, Z. Valerianova, T. Atanasov, O. Májek, J. Mužík, MC. Nilbert, AJ. Tybjerg, K. Innos, M. Mägi, N. Malila, AM. Bouvier, V. Bouvier, G. Launoy, AS. Woronoff, M. Cariou, M. Robaszkiewicz, P. Delafosse, F. Poncet, A. Katalinic, PM. Walsh, C. Senore, S. Rosso, I. Vincerževskienė, VEPP. Lemmens, MAG. Elferink, TB. Johannesen, H. Kørner, F. Pfeffer, MJ. Bento, J. Rodrigues, F. Alves da Costa, A. Miranda, V. Zadnik, T. Žagar, A. Lopez de Munain Marques, R. Marcos-Gragera, M. Puigdemont, J. Galceran, M. Carulla, MD. Chirlaque, M. Ballesta, K. Sundquist, J. Sundquist, M. Weber, A. Jordan, C. Herrmann, M. Mousavi, A. Ryzhov, M. Hoffmeister, H. Brenner
- 520 9_
- $a BACKGROUND: Colorectal cancer screening programmes and uptake vary substantially across Europe. We aimed to compare changes over time in colorectal cancer incidence, mortality, and stage distribution in relation to colorectal cancer screening implementation in European countries. METHODS: Data from nearly 3·1 million patients with colorectal cancer diagnosed from 2000 onwards (up to 2016 for most countries) were obtained from 21 European countries, and were used to analyse changes over time in age-standardised colorectal cancer incidence and stage distribution. The WHO mortality database was used to analyse changes over time in age-standardised colorectal cancer mortality over the same period for the 16 countries with nationwide data. Incidence rates were calculated for all sites of the colon and rectum combined, as well as the subsites proximal colon, distal colon, and rectum. Average annual percentage changes (AAPCs) in incidence and mortality were estimated and relevant patterns were descriptively analysed. FINDINGS: In countries with long-standing programmes of screening colonoscopy and faecal tests (ie, Austria, the Czech Republic, and Germany), colorectal cancer incidence decreased substantially over time, with AAPCs ranging from -2·5% (95% CI -2·8 to -2·2) to -1·6% (-2·0 to -1·2) in men and from -2·4% (-2·7 to -2·1) to -1·3% (-1·7 to -0·9) in women. In countries where screening programmes were implemented during the study period, age-standardised colorectal cancer incidence either remained stable or increased up to the year screening was implemented. AAPCs for these countries ranged from -0·2% (95% CI -1·4 to 1·0) to 1·5% (1·1 to 1·8) in men and from -0·5% (-1·7 to 0·6) to 1·2% (0·8 to 1·5) in women. Where high screening coverage and uptake were rapidly achieved (ie, Denmark, the Netherlands, and Slovenia), age-standardised incidence rates initially increased but then subsequently decreased. Conversely, colorectal cancer incidence increased in most countries where no large-scale screening programmes were available (eg, Bulgaria, Estonia, Norway, and Ukraine), with AAPCs ranging from 0·3% (95% CI 0·1 to 0·5) to 1·9% (1·2 to 2·6) in men and from 0·6% (0·4 to 0·8) to 1·1% (0·8 to 1·4) in women. The largest decreases in colorectal cancer mortality were seen in countries with long-standing screening programmes. INTERPRETATION: We observed divergent trends in colorectal cancer incidence, mortality, and stage distribution across European countries, which appear to be largely explained by different levels of colorectal cancer screening implementation. FUNDING: German Cancer Aid (Deutsche Krebshilfe) and the German Federal Ministry of Education and Research.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové rozložení $7 D017677
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kolorektální nádory $x epidemiologie $x mortalita $x patologie $7 D015179
- 650 12
- $a časná detekce nádoru $7 D055088
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a rozložení podle pohlaví $7 D017678
- 650 _2
- $a časové faktory $7 D013997
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Guo, Feng $u Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
- 700 1_
- $a Heisser, Thomas $u Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
- 700 1_
- $a Hackl, Monika $u Austrian National Cancer Registry, Statistics Austria, Vienna, Austria
- 700 1_
- $a Ihle, Petra $u Austrian National Cancer Registry, Statistics Austria, Vienna, Austria
- 700 1_
- $a De Schutter, Harlinde $u Belgian Cancer Registry, Brussels, Belgium
- 700 1_
- $a Van Damme, Nancy $u Belgian Cancer Registry, Brussels, Belgium
- 700 1_
- $a Valerianova, Zdravka $u Bulgarian National Cancer Registry, University Hospital of Oncology, Sofia, Bulgaria
- 700 1_
- $a Atanasov, Trajan $u Bulgarian National Cancer Registry, University Hospital of Oncology, Sofia, Bulgaria
- 700 1_
- $a Májek, Ondřej $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Mužík, Jan $u Institute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Nilbert, Mef Christina $u Danish Cancer Society Research Center, Copenhagen, Denmark; Department of Clinical Medicine, Hvidovre University Hospital, University of Copenhagen, Copenhagen, Denmark
- 700 1_
- $a Tybjerg, Anne Julie $u Danish Cancer Society Research Center, Copenhagen, Denmark
- 700 1_
- $a Innos, Kaire $u Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia
- 700 1_
- $a Mägi, Margit $u Estonian Cancer Registry, National Institute for Health Development, Tallinn, Estonia
- 700 1_
- $a Malila, Nea $u Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland
- 700 1_
- $a Bouvier, Anne-Marie $u Digestive Cancer Registry of Burgundy, University Hospital of Dijon, INSERM U1231, French Network of Cancer Registries (FRANCIM), Dijon, France
- 700 1_
- $a Bouvier, Véronique $u Digestive Tumors Registry of Calvados, University Hospital of Caen, U1086 INSERM UCN-ANTICIPE, French Network of Cancer Registries (FRANCIM), Caen, France
- 700 1_
- $a Launoy, Guy $u Interdisciplinary Research Unit for the Prevention and Treatment of Cancer, Normandy University, University of Caen Normandy, INSERM-ANTICIPE, Caen, France; Department of Research, University Hospital of Caen, Caen, France
- 700 1_
- $a Woronoff, Anne-Sophie $u Cancer Registry of Doubs, Centre Hospitalier Régional Universitaire Besançon, Besançon, France
- 700 1_
- $a Cariou, Mélanie $u Digestive Tumors Registry of Finistère, Centre Hospitalier Régional Universitaire Morvan, French Network of Cancer Registries (FRANCIM), Brest, France
- 700 1_
- $a Robaszkiewicz, Michel $u Digestive Tumors Registry of Finistère, Centre Hospitalier Régional Universitaire Morvan, French Network of Cancer Registries (FRANCIM), Brest, France
- 700 1_
- $a Delafosse, Patricia $u Cancer Registry of Isère, French Network of Cancer Registries (FRANCIM), Grenoble, France
- 700 1_
- $a Poncet, Florence $u Cancer Registry of Isère, French Network of Cancer Registries (FRANCIM), Grenoble, France
- 700 1_
- $a Katalinic, Alexander $u Cancer Registry of Schleswig-Holstein, Lübeck, Germany
- 700 1_
- $a Walsh, Paul M $u National Cancer Registry Ireland, Cork, Ireland
- 700 1_
- $a Senore, Carlo $u University Hospital 'Città della Salute e della Scienza', SSD Epidemiologia Screening-CPO Piemonte, Turin, Italy
- 700 1_
- $a Rosso, Stefano $u Piedmont Cancer Registry, Turin, Italy
- 700 1_
- $a Vincerževskienė, Ieva $u Lithuanian Cancer Registry, National Cancer Institute, Vilnius, Lithuania
- 700 1_
- $a Lemmens, Valery E P P $u Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
- 700 1_
- $a Elferink, Marloes A G $u Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands
- 700 1_
- $a Johannesen, Tom Børge $u Cancer Registry of Norway, Oslo, Norway
- 700 1_
- $a Kørner, Hartwig $u Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway
- 700 1_
- $a Pfeffer, Frank $u Department of Clinical Medicine, University of Bergen, Bergen, Norway; Department of Surgery, Haukeland University Hospital, Bergen, Norway
- 700 1_
- $a Bento, Maria José $u Department of Epidemiology, North Region Cancer Registry of Portugal, Portuguese Oncology Institute of Porto, Porto, Portugal; IPO Porto Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Population Studies, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal
- 700 1_
- $a Rodrigues, Jessica $u Department of Epidemiology, North Region Cancer Registry of Portugal, Portuguese Oncology Institute of Porto, Porto, Portugal; IPO Porto Research Center, Portuguese Oncology Institute of Porto, Porto, Portugal
- 700 1_
- $a Alves da Costa, Filipa $u Portuguese National Cancer Registry, Portuguese Oncology Institute of Lisbon, Lisbon, Portugal
- 700 1_
- $a Miranda, Ana $u Portuguese National Cancer Registry, Portuguese Oncology Institute of Lisbon, Lisbon, Portugal
- 700 1_
- $a Zadnik, Vesna $u Slovenian Cancer Registry, Institute of Oncology, Ljubljana, Slovenia
- 700 1_
- $a Žagar, Tina $u Slovenian Cancer Registry, Institute of Oncology, Ljubljana, Slovenia
- 700 1_
- $a Lopez de Munain Marques, Arantza $u Basque Country Cancer Registry, Vitoria-Gasteiz, Spain
- 700 1_
- $a Marcos-Gragera, Rafael $u Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health Government of Catalonia, Catalan Institute of Oncology, Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute, Salt, Spain; Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain
- 700 1_
- $a Puigdemont, Montse $u Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health Government of Catalonia, Catalan Institute of Oncology, Girona, Spain; Descriptive Epidemiology, Genetics and Cancer Prevention Group, Biomedical Research Institute, Salt, Spain
- 700 1_
- $a Galceran, Jaume $u Tarragona Cancer Registry, Epidemiology and Prevention Cancer Service, Hospital Universitari Sant Joan de Reus, Pere Virgili Health Research Institute, Reus, Spain
- 700 1_
- $a Carulla, Marià $u Tarragona Cancer Registry, Epidemiology and Prevention Cancer Service, Hospital Universitari Sant Joan de Reus, Pere Virgili Health Research Institute, Reus, Spain
- 700 1_
- $a Chirlaque, María-Dolores $u Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain; Tarragona Cancer Registry, Epidemiology and Prevention Cancer Service, Hospital Universitari Sant Joan de Reus, Pere Virgili Health Research Institute, Reus, Spain
- 700 1_
- $a Ballesta, Monica $u Consortium for Biomedical Research in Epidemiology and Public Health, Madrid, Spain; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain
- 700 1_
- $a Sundquist, Kristina $u Department of Clinical Sciences, Center for Primary Health Care Research, Lund University, Malmö, Sweden; Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Community-based Healthcare Research and Education, Department of Functional Pathology, School of Medicine, Shimane University, Shimane, Japan
- 700 1_
- $a Sundquist, Jan $u Department of Clinical Sciences, Center for Primary Health Care Research, Lund University, Malmö, Sweden; Department of Family Medicine and Community Health, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center for Community-based Healthcare Research and Education, Department of Functional Pathology, School of Medicine, Shimane University, Shimane, Japan
- 700 1_
- $a Weber, Marco $u Cancer Registry Bern-Solothurn, Bern, Switzerland
- 700 1_
- $a Jordan, Andrea $u Cancer Registry Bern-Solothurn, Bern, Switzerland
- 700 1_
- $a Herrmann, Christian $u Cancer Registry of Eastern Switzerland and Liechtenstein, St Gallen, Switzerland; Graubünden and Glarus Cancer Registry, Chur, Switzerland
- 700 1_
- $a Mousavi, Mohsen $u Cancer Registry of Eastern Switzerland and Liechtenstein, St Gallen, Switzerland; Graubünden and Glarus Cancer Registry, Chur, Switzerland
- 700 1_
- $a Ryzhov, Anton $u National Cancer Registry of Ukraine, National Institute of Cancer, Kyiv, Ukraine; Taras Shevchenko National University of Kyiv, Kyiv, Ukraine
- 700 1_
- $a Hoffmeister, Michael $u Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany
- 700 1_
- $a Brenner, Hermann $u Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany; German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany. Electronic address: h.brenner@dkfz.de
- 773 0_
- $w MED00006921 $t The Lancet. Oncology $x 1474-5488 $g Roč. 22, č. 7 (2021), s. 1002-1013
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34048685 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026133758 $b ABA008
- 999 __
- $a ok $b bmc $g 1714508 $s 1145986
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 22 $c 7 $d 1002-1013 $e 20210525 $i 1474-5488 $m Lancet neurology $n Lancet Neurol $x MED00006921
- LZP __
- $a Pubmed-20211013
